Comparison of High and Low Doses of Trimethoprim-Sulfamethoxazole for Primary Prevention of Toxoplasmic Encephalitis in Human Immunodeficiency Virus-Infected Patients-Reference-Cited by-同舟云学术

Comparison of High and Low Doses of Trimethoprim-Sulfamethoxazole for Primary Prevention of Toxoplasmic Encephalitis in Human Immunodeficiency Virus-Infected Patients

Published:1999-12-01 Issue:6 Volume:29 Page:1461-1466
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clinical Infectious Diseases

Author:

Ribera E.,Fernandez-Sola A.,Juste C.,Rovira A.,Romero F. J.,Armadans-Gil L.,Ruiz I.,Ocana I.,Pahissa A.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/29/6/1461/869925/29-6-1461.pdf

Reference25 articles.

1. 1997 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: Disease‐Specific Recommendations

2. Preventing Toxoplasmic Encephalitis in Persons Infected with Human Immunodeficiency Virus

3. A Meta-analysis of the Relative Efficacy and Toxicity of Pneumocystis carinii Prophylactic Regimens

4. Meta-Analysis of Prophylactic Treatments Against Pneumocystis carinii Pneumonia and Toxoplasma Encephalitis in HIV-Infected Patients

5. Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intracellular Pathogen in the Cerebrospinal Fluid of an Allogeneic Hematopoietic Cell Transplant Recipient With Graft-Versus-Host Disease and Brain Lesions;Clinical Infectious Diseases;2020-12-01

2. Failures of once‐a‐week trimethoprim‐sulfamethoxazole prophylaxis in children undergoing allogeneic hematopoietic stem cell transplant;Transplant Infectious Disease;2019-12-27

3. Prophylaxis of human toxoplasmosis: a systematic review;Pathogens and Global Health;2017-09-26

4. Suboptimal cotrimoxazole prophylactic concentrations in HIV‐infected children according to the WHO guidelines;British Journal of Clinical Pharmacology;2017-09-20

5. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review;Expert Review of Anti-infective Therapy;2017-08-21